Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Wolchok

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Annals of Internal Medicine|March 15, 1997
Treatment of Behçet disease with pentoxifyllineJ D Wolchok
Journal of the National Cancer Institute|June 19, 1991
There is more to hemorrhagic necrosis than tumor necrosis factorJ D Wolchok, J Vilcek
Cytokine|November 1, 1992
Induction of HLA class I mRNA by cytokines in human fibroblasts: comparison of TNF, IL-1 and IFN-betaJ D Wolchok, J Vilcek
The Lancet. Oncology|March 22, 2002
Vaccines for melanoma: translating basic immunology into new therapiesJ D Wolchok, P O Livingston
Cytotherapy|October 21, 2005
Persistence makes perfect: the benefits of IL-2 in adoptive immunotherapyG A Rizzuto, J D Wolchok
Oncology (Williston Park, N.Y.)|February 19, 2000
Management of renal cell carcinomaJ D Wolchok, R J Motzer
British Journal of Cancer|September 12, 2014
Immune modulation for cancer therapyJ Naidoo, D B Page, J D Wolchok
Journal of Leukocyte Biology|January 1, 1994
Activation of NF-kappa B may be necessary but is not sufficient for induction of H-2 antigens by TNF in J558L murine myeloma cellsJ D Wolchok, A R Goodman, J Vilcek
Hematology/Oncology Clinics of North America|October 6, 1998
Vaccines and other adjuvant therapies for melanomaJ D Wolchok, P O Livingston, A N Houghton
Urology|March 24, 1998
Localized squamous cell carcinoma of the bladder causing hypercalcemia and inhibition of PTH secretionJ D Wolchok, H W Herr, W K Kelly
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Annals of Internal Medicine|March 15, 1997
Treatment of Behçet disease with pentoxifyllineJ D Wolchok
Journal of the National Cancer Institute|June 19, 1991
There is more to hemorrhagic necrosis than tumor necrosis factorJ D Wolchok, J Vilcek
Cytokine|November 1, 1992
Induction of HLA class I mRNA by cytokines in human fibroblasts: comparison of TNF, IL-1 and IFN-betaJ D Wolchok, J Vilcek
The Lancet. Oncology|March 22, 2002
Vaccines for melanoma: translating basic immunology into new therapiesJ D Wolchok, P O Livingston
Cytotherapy|October 21, 2005
Persistence makes perfect: the benefits of IL-2 in adoptive immunotherapyG A Rizzuto, J D Wolchok
Oncology (Williston Park, N.Y.)|February 19, 2000
Management of renal cell carcinomaJ D Wolchok, R J Motzer
British Journal of Cancer|September 12, 2014
Immune modulation for cancer therapyJ Naidoo, D B Page, J D Wolchok
Journal of Leukocyte Biology|January 1, 1994
Activation of NF-kappa B may be necessary but is not sufficient for induction of H-2 antigens by TNF in J558L murine myeloma cellsJ D Wolchok, A R Goodman, J Vilcek
Hematology/Oncology Clinics of North America|October 6, 1998
Vaccines and other adjuvant therapies for melanomaJ D Wolchok, P O Livingston, A N Houghton
Urology|March 24, 1998
Localized squamous cell carcinoma of the bladder causing hypercalcemia and inhibition of PTH secretionJ D Wolchok, H W Herr, W K Kelly
Pageof 4